Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | Y49BZ | — |
Vaccine inappropriate age administration; of 4 months old instead of the correct age vaccine and this was supposed to be the second dose in the DTaP series; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number Y49BZ, expiry date 17-MAY-2026) for prophylaxis. On 15-MAY-2025, the patient received the 2nd dose of Kinrix. On 15-MAY-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Vaccine inappropriate age administration) and inappropriate schedule of vaccine administered (Verbatim: of 4 months old instead of the correct age vaccine and this was supposed to be the second dose in the DTaP series). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:15-MAY-2025 The reporter called to inform that a Kinrix vaccine dose was administered to a female patient of 4 months old instead of the correct age vaccine and this was supposed to be the second dose in the DTaP series, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. The reporter wanted to know how to proceed. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up.